Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

47.35
Delayed Data
As of Apr 25
 +0.60 / +1.28%
Today’s Change
29.95
Today|||52-Week Range
50.05
+18.82%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close46.75
Today’s open46.80
Day’s range46.40 - 47.70
Volume634,531
Average volume (3 months)659,526
Market cap$2.3B
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)-38.64%
Earnings growth (this year)+74.54%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+40.57%
P/E ratio43.8
Price/Sales7.03
Price/Book8.60

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.22-1.60%
PRTAProthena Corporation...-0.10-0.86%
IRWDIronwood Pharmaceuti...+0.01+0.06%
HZNPHorizon Pharma PLC-0.08-0.58%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)$0.24
Annual revenue (last year)$302.2M
Annual profit (last year)$57.3M
Net profit margin18.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts